EVENT CANCELLED!!
Very sorry to announce this event has been cancelled for now. We hope to hold it on a future date. Thanks!
A Canadian Perspective of Device Innovation in MedTech: From Concept to Commercialization.
Taking Combination Products to the Next Level: Combining Advanced Therapies and Medical Devices
AI In MedTech: Reshaping Dermataology & Oncology Healthcare
Who Should Attend: Researchers and companies interested in learning ore about medical devices including AI, Diagnostics, Combination Products, and taking MedTech from concept to commercialization
Speakers:
David Warwick, Director at eg Technology (https://www.egtechnology.co.uk/)
Frank Shannon, VP Clinical Development & Regulatory Affairs, Sernova (https://www.sernova.com/)
Keith Loo, Co-Founder & CEO, Skinopathy (https://skinopathy.com/)
Learning Objectives:
- How to use standards to help you meet the requirements of the medical device regulations
- Why adopting a risk-based approach is the key to successful medical device development
- The importance of understanding user needs and the application of usability engineering
- Discuss innovation and concept of Sernova’s cell pouch system in addressing unmet needs in Diabetes, Haemophilia and beyond
- Review the opportunities and challenges with the development of Combination MedTech products from a Canadian company’s perspective
- Review the concept and development stage of Skinopathy-an AI Medtech Diagnostic Device including implementing practical use in real world settings
- Discuss the regulatory approval & commercialization path
- Discuss addressing the dermatology gap of assessing & diagnosis of skin disease in Skin of Colour (SOC) (previous study found 47% of dermatologists felt training was inadequate to diagnose disease in SOC patients)
